Holen Sie sich die Stockscreener-App
0.73
3.52%
0.0248
Handel nachbörslich:
.72
-0.01
-1.37%
Heartbeam Inc Aktie (BEAT) Neueste Nachrichten
How institutional buying supports HeartBeam Inc. stockEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Why hedge funds are buying HeartBeam Inc. stockEarnings Miss & Technical Entry and Exit Alerts - Newser
Will HeartBeam Inc. stock maintain dividend yieldMarket Rally & Fast Exit Strategy with Risk Control - Newser
What is the fair value of HeartBeam Inc. Equity Warrant stock nowQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - Newser
HeartBeam Pursues Regulatory Path After FDA Decision on ECG Software - citybuzz
HeartBeam (NASDAQ: BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - Digital Journal
HeartBeam (BEAT) Outlines Regulatory Strategy After NSE Decision on ECG Synthesis Software - NewMediaWire
HeartBeam Outlines Regulatory Strategy Following FDA Decision on ECG Software - citybuzz
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Breakout Watch & Fast Gain Swing Alerts - moha.gov.vn
Biotech Minors Make Major Moves On FDA News And Stock Sales - Finimize
HeartBeam’s Strategic Path to Overcome Regulatory Challenges and Secure Buy Rating - TipRanks
Crude Oil Gains 1%; Tilray Brands Shares Plunge - Benzinga
Nasdaq Rises 100 Points; Chagee Shares Gain After Q3 Results - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
HeartBeam Outlines Regulatory Path Following FDA NSE Decision On 12-Lead ECG Synthesis Software - Nasdaq
Is HeartBeam Inc. stock dividend yield sustainableGold Moves & Safe Capital Growth Plans - BỘ NỘI VỤ
What's Behind HeartBeam's Over 40% After-Hours Surge? - Benzinga
HeartBeam, Inc. (BEAT) Stock: Soars as FDA Appeal Strategy Sparks Investor Optimism - parameter.io
HeartBeam pursues multiple options after FDA rejection of ECG software By Investing.com - Investing.com Nigeria
Heartbeam provides update on regulatory path following FDA decision on 12-lead ECG synthesis software application - marketscreener.com
Heartbeam Provides Update On Regulatory Path Following FDA Decision On 12-Lead ECG Synthesis Software Application - TradingView
HeartBeam pursues multiple options after FDA rejection of ECG software - Investing.com
HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application - The AI Journal
HeartBeam stock surges after FDA signals path forward on ECG software - Investing.com Nigeria
HeartBeam updates regulatory strategy for 12-lead ECG Synthesis Software - TipRanks
HeartBeam stock surges after FDA signals path forward on ECG software By Investing.com - Investing.com South Africa
HeartBeam : Earnings Documents - marketscreener.com
HeartBeam, Inc. Earnings Call Highlights Progress and Challenges - MSN
Is HeartBeam Inc Equity Warrant a good long term investmentMerger & Acquisition Updates & Hidden Gems with Outstanding Profit Margins - earlytimes.in
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2025 Earnings Call Transcript - MSN
FDA Letter, AI Worries, And Weak Earnings Rattle Key Stocks - Finimize
Roth sees potential FDA clearance for HeartBeam despite letter - TipRanks
HeartBeam Shares Fall After 510(k) Rejection From US FDA for ECG Software Application - MarketScreener
HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
HeartBeam says received NSE letter from FDA for 12-lead ECG synthesis softwareSEC filing - marketscreener.com
HeartBeam receives FDA NSE letter for ECG software, evaluates 3D ECG system launch - Investing.com Nigeria
HeartBeam receives FDA NSE letter for ECG software, evaluates 3D ECG system launch By Investing.com - Investing.com South Africa
HeartBeam Receives FDA NSE Letter for ECG Software - TradingView
[8-K] HeartBeam, Inc. Reports Material Event | BEAT SEC FilingForm 8-K - Stock Titan
How rising interest rates impact HeartBeam Inc. stockEarnings Risk Summary & Reliable Trade Execution Plans - newser.com
Will HeartBeam Inc. Equity Warrant stock continue upward momentumProduct Launch & Fast Exit/Entry Strategy Plans - newser.com
Can HeartBeam Inc. stock surprise with earnings upsideJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Can HeartBeam Inc. stock hit record highs again2025 Dividend Review & Weekly Market Pulse Updates - newser.com
Can HeartBeam Inc. Equity Warrant stock resist sector downturnsJuly 2025 Summary & Reliable Volume Spike Alerts - newser.com
HeartBeam (NASDAQ: BEAT) Poised in the Future of Cardiac Care with Breakthrough Technology - Digital Journal
HeartBeam (BEAT) Poised in the Future of Cardiac Care With Breakthrough Technology - Yahoo Finance
1.88%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):